INS and type 2 diabetes mellitus: Though NOS regulation in platelets is currently under discussion, the insulin-induced cGMP synthesis is decreased and agonist-induced platelet aggregation is insensitive to NOS inhibitors in T2DM patients (Randriamboavonjy and Fleming, 2009).